University of Melbourne, Parkville, Victoria, 3050, Australia; Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia.
Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia.
Infect Dis Health. 2022 May;27(2):61-65. doi: 10.1016/j.idh.2021.10.002. Epub 2021 Nov 16.
Various styles of N95/P2 filtering facepiece respirators (FFRs) have been used by Australian healthcare workers (HCWs) during the COVID-19 pandemic. This is usually driven by the national stockpile availability. Many studies demonstrate three-panel flat-fold N95/P2 FFRs have higher quantitative fit test (QNFT) pass rates than other FFR styles. This prospective randomized crossover study utilized QNFT to evaluate the performance of the new three-panel flat-fold FFR, the Trident™ P2 respirator compared to the previously most effective model, the 3M™ Aura™ 9320A + N95 respirator.
We recruited 500 participants who completed online training and QNFT on both respirators. The order of the respirator being examined first was randomly allocated. The primary outcome was the QNFT pass rate. Secondary outcomes included the overall fit factor, the individual fit factor for each exercise, and the first-attempt QNFT pass rate.
We found that both the overall and first-attempt QNFT pass rates of the Trident P2 respirator were significantly higher than the 3M Aura (99.2% vs 92.6%, p < 0.001; and 92.6% vs 76.4%, p < 0.001 respectively). The overall fit factor and the individual fit factor were also significantly higher for the Trident FFR than the 3M Aura.
This study is the first to report hospital-based QNFT results of the Trident FFR, demonstrating very high first-time and overall pass rates. Our findings are consistent with previous research showing very high QNFT pass rates with three-panel flat-fold FFRs. These findings are important for pandemic preparedness with respect to the stockpiling and safe utilization of N95/P2 respirators.
在 COVID-19 大流行期间,澳大利亚医护人员(HCWs)使用了各种样式的 N95/P2 过滤式口罩(FFR)。这通常是由国家库存的可用性决定的。许多研究表明,三面板折叠式 N95/P2 FFR 的定量 fit test(QNFT)通过率高于其他 FFR 样式。这项前瞻性随机交叉研究利用 QNFT 评估了新型三面板折叠式 FFR,Trident™ P2 呼吸器与之前最有效的型号,3M™ Aura™ 9320A + N95 呼吸器的性能。
我们招募了 500 名参与者,他们在两种呼吸器上都完成了在线培训和 QNFT。检查第一种呼吸器的顺序是随机分配的。主要结果是 QNFT 通过率。次要结果包括整体拟合因子、每个练习的个体拟合因子和首次 QNFT 通过率。
我们发现 Trident P2 呼吸器的整体和首次 QNFT 通过率均明显高于 3M Aura(99.2%比 92.6%,p<0.001;92.6%比 76.4%,p<0.001)。Trident FFR 的整体拟合因子和个体拟合因子也明显高于 3M Aura。
这项研究首次报告了基于医院的 Trident FFR 的 QNFT 结果,显示出非常高的首次和整体通过率。我们的发现与之前的研究一致,即三面板折叠式 FFR 的 QNFT 通过率非常高。这些发现对于 N95/P2 呼吸器的储备和安全使用的大流行准备工作非常重要。